Ronald Muhlenkamp
Muhlenkamp & Co
Muhlenkamp & Co Portfolio 13F
Ronald Muhlenkamp Holdings Activity
- Portfolio value:
- $236.04M≈ (+$12M≈)
- Previous value:
- $223.96M≈
- # of changes:
- 27
- New positions:
- 2
- Reported for:
- 31 Dec 2022 (Q4)
- Latest filing date:
- 31 Jan 2023
Muhlenkamp & Co has disclosed a total of 27 changes to the portfolio in the (2022 Q4) SEC report(s): increased the number of shares of 8, bought 2 totally new, decreased the number of shares of 15 and completely sold out 2 position(s).
What stocks did Ronald Muhlenkamp buy in 2022 Q4?
During 2022 Q4 Ronald Muhlenkamp has bought 10 securities out of which top 5 purchases (by % change to portfolio) were (MCK) McKesson Corp (added shares +0.10%), (PSQ) ProShares Short QQQ (new buy), (UNH) UnitedHealth Group Incorporated (added shares +0.08%), (BRK-B) Berkshire Hathaway Inc (added shares +0.10%) and (AMLP) Alerian MLP ETF (added shares +0.09%).
In the 2022 Q4 report(s) the following changes have been made to the top investments: (SLB) Schlumberger NV (reduced shares -0.09%), (EQT) EQT Corp (reduced shares -0.10%), (OXY) Occidental Petroleum Corp (reduced shares -0.10%), (MCK) McKesson Corp (added shares +0.10%) and (PSQ) ProShares Short QQQ (new buy).
27 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Exxon Mobil Corp
|
new
|
+1,952
|
1,952
|
+0.09%
|
$110.30
|
+39.85%($154.26)
|
0.09%
|
2022 Q4
|
≈ 0.25 years
|
|
|
|
ProShares Short QQQ
|
new
|
+180,975
|
180,975
|
+5.64%
|
$73.60
|
-63.61%($26.78)
|
5.64%
|
2022 Q4
|
≈ 0.25 years
|
|
|
|
Franco-Nevada Corp
|
+0.19%
|
+71
|
38,385
|
+0%
|
$136.48
|
+56.59%($213.72)
|
2.22%
|
2020 Q4
|
≈ 2.25 years
|
|
|
|
Royal Gold Inc
|
+0.16%
|
+77
|
46,932
|
+0%
|
$112.72
|
+75.29%($197.59)
|
2.24%
|
2020 Q4
|
≈ 2.25 years
|
|
|
|
Bristol-Myers Squibb Company
|
+0.15%
|
+197
|
128,950
|
+0.01%
|
$71.95
|
-9.49%($65.12)
|
3.93%
|
2019 Q4
|
≈ 3.00 years
|
|
|
|
CVS Health Corp
|
+0.11%
|
+122
|
110,123
|
+0%
|
$93.19
|
+12.96%($105.26)
|
4.35%
|
2019 Q3
|
≈ 3.25 years
|
|
|
|
McKesson Corp
|
+0.10%
|
+40
|
38,249
|
+0.01%
|
$375.12
|
+129.61%($861.33)
|
6.08%
|
2016 Q2
|
≈ 6.25 years
|
|
|
|
Berkshire Hathaway Inc
|
+0.10%
|
+36
|
37,430
|
+0%
|
$308.90
|
+65.71%($511.88)
|
4.90%
|
2019 Q3
|
≈ 3.25 years
|
|
|
|
Alerian MLP ETF
|
+0.09%
|
+260
|
284,317
|
+0%
|
$38.07
|
+45.02%($55.21)
|
4.59%
|
2018 Q1
|
≈ 4.50 years
|
|
|
|
UnitedHealth Group Incorporated
|
+0.08%
|
+19
|
24,755
|
+0%
|
$530.18
|
-20.90%($419.36)
|
5.56%
|
2016 Q1
|
≈ 6.50 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.